LAZZARI, Ilaria
 Distribuzione geografica
Continente #
NA - Nord America 292
EU - Europa 239
AS - Asia 52
SA - Sud America 1
Totale 584
Nazione #
US - Stati Uniti d'America 286
PL - Polonia 136
IT - Italia 29
CN - Cina 26
GB - Regno Unito 24
DE - Germania 19
UA - Ucraina 19
SG - Singapore 10
TR - Turchia 10
CA - Canada 6
SE - Svezia 6
FI - Finlandia 3
ID - Indonesia 2
TW - Taiwan 2
ES - Italia 1
FR - Francia 1
NL - Olanda 1
PK - Pakistan 1
VE - Venezuela 1
VN - Vietnam 1
Totale 584
Città #
Warsaw 136
Fairfield 45
Houston 36
Woodbridge 27
Ann Arbor 21
Jacksonville 19
Seattle 18
Ashburn 17
Wilmington 15
Chandler 14
Munich 11
Cambridge 9
Mcallen 9
Ferrara 8
Cagliari 6
Izmir 6
Nanjing 6
Montréal 5
Princeton 5
Shenyang 5
Singapore 5
New York 4
Boardman 3
Dearborn 3
San Diego 3
Auburn Hills 2
Beijing 2
Casalbuttano ed Uniti 2
Indiana 2
Jakarta 2
Jiaxing 2
Milan 2
Nanchang 2
Philadelphia 2
Santa Clara 2
Shanghai 2
Zhengzhou 2
Amsterdam 1
Bari 1
Bologna 1
Castrovillari 1
Changsha 1
Chicago 1
Dallas 1
Des Moines 1
Distrito Federal 1
Dong Ket 1
Ebhausen 1
Haikou 1
Kunming 1
Los Angeles 1
Madrid 1
Mountain View 1
Nanterre 1
Ningbo 1
Rome 1
Saidu Sharif 1
San Mateo 1
Siziano 1
Taipei 1
Taizhou 1
Toronto 1
Verona 1
Totale 486
Nome #
SINTESI E ATTIVITA’ BIOLOGICA DI LIGANDI DEL RECETTORE OPPIOIDE DOP 194
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide. 146
C-terminal constrained phenylalanine as a pharmacophoric unit in peptide-based proteasome inhibitors 137
null 96
Further studies on the effect of lysine at the C-terminus of the Dmt-Tic opioid pharmacophore 13
Totale 586
Categoria #
all - tutte 1.730
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.730


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020147 0 0 6 22 12 17 13 18 17 22 11 9
2020/2021105 12 9 10 9 13 14 5 9 3 12 4 5
2021/202247 1 3 8 0 3 2 4 1 0 2 6 17
2022/202333 3 2 2 4 8 1 3 5 2 0 2 1
2023/202430 3 2 0 0 1 5 0 6 0 0 1 12
2024/202521 2 8 11 0 0 0 0 0 0 0 0 0
Totale 586